Pauls Matthew insider trades
Pauls Matthew has filed 24 Form 4s with the SEC that we hold, for Savara Inc (SVRA) (CHIEF EXECUTIVE OFFICER, Director), Pelthos Therapeutics Inc. (PTHS) (Director), SLNO (Director) and Palvella Therapeutics, INC. (PVLA) (Director). Across all of them we count 7 purchases worth $74.2K and 8 sales worth $1.1M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($53.5K). The largest single trade was a sale of 5,937 shares of SLNO worth $424.8K, dated 2025-03-28. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-18 and the latest 2026-10-06.
Savara Inc (SVRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-17 | P, purchase reported on Form 4 | 15,000 | $17.7K | 2021-08-18 |
| 2021-08-18 | P, purchase reported on Form 4 | 11,900 | $14.2K | 2021-08-18 |
| 2021-11-18 | P, purchase reported on Form 4 | 10,000 | $11.0K | 2021-11-22 |
| 2021-11-19 | P, purchase reported on Form 4 | 2,150 | $2.3K | 2021-11-22 |
| 2021-11-19 | P, purchase reported on Form 4 | 10,000 | $11.1K | 2021-11-22 |
| 2021-12-02 | P, purchase reported on Form 4 | 10,000 | $11.0K | 2021-12-02 |
| 2021-12-08 | P, purchase reported on Form 4 | 6,500 | $6.9K | 2021-12-08 |
| 2023-12-28 | S, sale reported on Form 4 | 84,000 | $395.6K | 2023-12-29 |
| 2024-12-16 | S, sale reported on Form 4 | 54,702 | $181.1K | 2024-12-16 |
Pelthos Therapeutics Inc. (PTHS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-04-02 | S, sale reported on Form 4 | 371 | $7.9K | 2026-04-06 |
| 2026-04-02 | S, sale reported on Form 4 | 415 | $8.5K | 2026-04-06 |
| 2026-07-02 | S, sale reported on Form 4 | 692 | $18.0K | 2026-07-07 |
| 2026-07-02 | S, sale reported on Form 4 | 94 | $2.6K | 2026-07-07 |
| 2026-10-02 | S, sale reported on Form 4 | 786 | $16.5K | 2026-10-06 |
SLNO
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-03-28 | S, sale reported on Form 4 | 5,937 | $424.8K | 2025-03-31 |
Palvella Therapeutics, INC. (PVLA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1573429) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms